Clinical trials

  • EFGARTIGIMOD ALFA for Generalized myasthenia gravis (AChR‑Ab seronegative)
  • NALOXEGOL OXALATE for Traumatic brain injury|Subarachnoid haemorrhage|Opioid-induced gastrointestinal motility disorder
  • DANICOPAN for Paroxysmal nocturnal hemoglobinuria
  • Paroxetine hydrochloride for Major Depressive Disorder
  • ZIDESAMTINIB for Advanced ROS1-positive non-small cell lung cancer (NSCLC) | Advanced ROS1-positive solid tumors
  • LONCASTUXIMAB TESIRINE for Mantle cell lymphoma
  • LORLATINIB for Advanced ROS1-positive non-small cell lung cancer
  • Isatuximab for Multiple myeloma|High-risk multiple myeloma
  • ATEZOLIZUMAB for Hodgkin lymphoma
  • DEXAMETHASONE for Cervicobrachial neuralgia
  • HCT116-A, HCT116-B, HT-29-A, HT-29-B, LOVO-B, LOVO-A for Colorectal cancer (unresectable locally advanced or metastatic)
  • Daratumumab for T-cell acute lymphoblastic leukemia (very high-risk)